Shattuck lecture: Clinical research to clinical practice - Lost in translation?

New England Journal of Medicine

Volumn 349, Issue 9, 2003, Pages 868-874

  Lenfant, Claude ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HUMAN; LIFE EXPECTANCY; PATIENT ATTITUDE; REVIEW; UNITED STATES;

EID: 0042431931     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMsa035507     Document Type: Review

References (29)

1. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and treatment. JAMA 1997;277:535-42.
2. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, D.C.: National Academy Press, 2001.
3. Berwick DM. Disseminating innovations in health care. JAMA 2003;289:1969-75.
4. Schwartz K, Vilquin JT. Building the translational highway: toward new partnerships between academia and the private sector. Nat Med 2003;9:493-5.
5. Sung NS, Crowley WF Jr, Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA 2003;289: 1278-87.
6. β-Blocker Heart Attack Study Group. The β-Blocker Heart Attack Trial. JAMA 1981; 246:2073-4.
7. The state of managed care quality. Washington, D.C.: National Committee for Quality Assurance. 1997.
8. The state of managed care quality. Washington, D.C.: National Committee for Quality Assurance, 1999.
9. Awtry EH, Loscalzo J. Aspirin. Circulation 2000;101:1206-18.
10. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 2003; 41:56-61.
11. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1996; 94:2341-50.
12. Ryan TJ, Antman EM, Brooks NH, et al. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999;100: 1016-30.
13. National Registry of Myocardial Infarction. NMRI 4 quarterly data report 2002. South San Francisco, Calif.: Genentech, 2002.
14. O'Connor GT, Quinton HB, Traven ND, et al. Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA 1999;281: 627-33.
15. Schneider EC, Leape LL, Weissman JS, Piana RN, Gatsonis C, Epstein AM. Racial differences in cardiac revascularization rates: does "overuse" explain higher rates among white patients? Ann Intern Med 2001;135: 328-37.
16. Califf RM, DeLong ER, Ostbye T, et al. Underuse of aspirin in a referral population with documented coronary artery disease. Am J Cardiol 2002;89:653-61.
17. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Sloan survey. JAMA 2002;287:337-44.
18. Lee JY, Kusek JW, Greene PG, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1996;9:719-25.
19. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998;20:671-81.
20. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393-405.
21. Galuska DA, Will JC, Serdula MK, Ford ES. Are health care professionals advising obese patients to lose weight? JAMA 1999; 282:1576-8.
22. Wee CC, McCarthy EP, David RB, Phillips RS. Physician counseling about exercise. JAMA 1999;282:1583-8.
23. The state of health care quality. Washington, D.C.: National Committee for Quality Assurance, 2002.
24. Morrison AC, Doris PA, Folsom AR, Nieto FJ, Boerwinkle E. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 2001;32:822-9.
25. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein beta(3)-subunitand antihypertensive response to a thiazide diuretic. Hypertension 2001;37:739-43.
26. Wu KK, Aleksic N, Ahn C, Boerwinkle E, Folsom AR, Juneja H. Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease. Circulation 2001;103: 1386-9.
27. 1C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002;347:1135-42.
28. Willett WC. Balancing life-style and genomics research for disease prevention. Science 2002;296:695-8.
29. Rees J. Complex disease and the new clinical sciences. Science 2002;296:698-700.